Nav: Home

PKM2 promotes exosome release via phosphorylating SNAP-23

January 09, 2017

In a study newly published in Nature Communications, A research team led by Dr. Ke Zen and Chen-Yu Zhang from Nanjing University reports that pyruvate kinase type M2 promotes tumor cell exosome release through phosphorylating synaptosome-associated protein 23.

As a mechanism to communicate with the microenvironment, tumor cells actively release large amount of microvesicles (MVs) particularly exosomes. These tumor-released MVs, which are abundant in the body fluids of patients with cancer, play a critical role in promoting tumor growth and progression. The mechanism underlying the active exocytosis of exosomes by tumor cells, however, remains incompletely understood. It has been reported that cellular exocytosis activity is increased during tumorigenesis, but the molecular basis to switch on the exocytosis process in tumor cells has not been identified.

In the present study, Nanjing University team showed that PKM2, an enzyme involved in the tumor cell's reliance on aerobic glycolysis (Warburg effect), plays a critical role in promoting the release of exosomes from the tumor cell. In specific, they identify SNAP-23, which controls the dock and release of secretory granules or exosome-containing multivesicular bodies (MVBs), is a substrate of PKM2 in tumor cells. During exocytosis, phosphorylated PKM2 is recruited to secretory granules or MVBs near cell's membranes where it associates with SNAP-23 and phosphorylates SNAP-23 at Ser95, leading to upregulation of exocytosis in tumor cells. This study demonstrates for the first time that PKM2 plays an essential role in not only switching tumor cell metabolism from oxidative phosphorylation to aerobic glycolysis, but also promoting tumor cell exocytosis via directly phosphorylating SNAP-23. Given that Warburg effect switched on by PKM2 is also an important metabolism mechanism for many non-tumor cells, such as immune cells, the PKM2-mediated secretion may also play a significant role in modulating the secretion or degranulation process in these cells under inflammatory stimuli.
-end-
The researchers of this project include Yao Wei, Dong Wang, Fangfang Jin, Mingzhen Li, Chaoyun Pan, Dihan Zhu, Limin Li, Chen-Yu Zhang and Ke Zen from State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University Advanced Institute for Life Sciences (NAILS), Nanjing University School of life sciences (163 Xianlin Road, Nanjing, Jiangsu, 210046), and collaborators Dr. Gang Hu from Nanjing University of Traditional Chinese Medicine (Nanjing, China), and Drs. Yuan Liu, Zhen Bian and Lei Shi from Georgia State University (Atlanta, GA, USA). This work was supported by grants the National Basic Research Program of China (973 Program) (No. 2012CB517603 and 2014CB542300).

Nanjing University School of Life Sciences

Related Tumor Cells Articles:

When healthy cells stimulate the migration of tumor cells
Estrogens act as a driving force of both healthy and cancerous mammary cell growth by binding to receptors that include GPER, which is generally located in cell membranes.
Tumor cells get stiff before becoming invasive
A study published now on Nature Communications shows that breast cancer cells undergo a stiffening state prior to acquiring malignant features and becoming invasive.
Tumor-trained T cells go on patrol
In cancer, immune cells infiltrate tumors -- but it hasn't been known which immune cells exit the tumor or where they go next.
Tumor-dwelling immune cells thwart cancer immunotherapy
Researchers have caught tumor-associated immune cells called macrophages in the act of stealing checkpoint inhibitor antibodies away from their intended T cell targets, and blocking this thievery led to improved therapeutic responses in tumor-bearing mice.
Are tumor cells glutamine addicts?
Many tumors are thought to depend on glutamine, suggesting glutamine deprivation as therapeutic approach, but a new study shows that this effect might have been overestimated.
Tethered nanoparticles make tumor cells more vulnerable
MIT researchers have devised a way to make cancer cells more susceptible to certain types of cancer treatment, by coating the cells with nanoparticles before delivering drugs.
Researchers create viruses to selectively attack tumor cells
It is an innovative approach that takes advantage of the different expression profiles of certain proteins between tumor and healthy cells that make the virus to only infect the first ones.
Scientists use tumor-derived dendritic cells to slow tumor growth
In the human body, so-called dendritic cells are responsible for activating our immune system.
Tumor cells are dependent on fat to start metastasis
A study headed by Salvador Aznar Benitah, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona), and published today in Nature identifies metastasis-initiating cells through a specific marker, namely the protein CD36.
Once inside a tumor, our immune cells become traitors
New research has found a subset of our immune cells (called regulatory T cells) that are highly abundant in the tumor microenvironment and are particularly good at suppressing the anticancer immune response.

Related Tumor Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".